Evidence map›Paper›PMID 42009311›Full record

ArticleMolecular pharmaceutics2026

Combining PC-SAFT and ML to Access Unknown API Solubilities.

Jonas Habicht, Gabriele Sadowski, Christoph Brandenbusch

Abstract read
In one paragraph

Article in Molecular pharmaceutics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Jonas HabichtTU Dortmund University, Laboratory of Thermodynamics, Department of Biochemical and Chemical Engineering, Emil-Figge-Str. 70, Dortmund 44227, Germany.ORCID 0009-0001-8365-5170
Gabriele SadowskiTU Dortmund University, Laboratory of Thermodynamics, Department of Biochemical and Chemical Engineering, Emil-Figge-Str. 70, Dortmund 44227, Germany.ORCID 0000-0002-5038-9152
Christoph BrandenbuschTU Dortmund University, Laboratory of Thermodynamics, Department of Biochemical and Chemical Engineering, Emil-Figge-Str. 70, Dortmund 44227, Germany.ORCID 0000-0003-3338-9211

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Predicting the solubility of active pharmaceutical ingredients (APIs) is essential throughout drug development. However, state-of-the-art modeling approaches require system-specific data sets for parameter estimation and are resource intensive. This work introduces a new method that integrates adaptive machine learning (ML) methods with PC-SAFT modeling to vastly reduce requirements of experimental data. Instead of extensive experimental campaigns of solubility measurements, only the molecular structure and melting properties of the API are needed - information onten available in literature or easily measured. The ML framework applied in this work supplies PC-SAFT parameters for APIs. With solvent parameters already available from literature, this novel approach provided highly accurate solubility estimations for 21 APIs in pure solvents (

Indexed as

Machine LearningChemistry, PharmaceuticalPrediction AlgorithmsPredictive Learning ModelsSolubilitySolventsThermodynamicsSolventsAPImachine learningneural networksPC-SAFTsolubility

Identifiers

PMID42009311
PMCPMC13147324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.